moxisylyte has been researched along with Prostatic Diseases in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitker, MO | 1 |
| Veaux Renault, V | 1 |
| Pichon, J | 1 |
| Perrigot, M | 1 |
| Chatelain, C | 1 |
1 other study available for moxisylyte and Prostatic Diseases
| Article | Year |
|---|---|
[The uretheral syndrome in men or prostatodynia].
Topics: Adult; Genital Diseases, Male; Humans; Male; Middle Aged; Moxisylyte; Pain; Prostatic Diseases; Synd | 1988 |